| UniProt ID | TRIPB_HUMAN | |
|---|---|---|
| UniProt AC | Q15643 | |
| Protein Name | Thyroid receptor-interacting protein 11 | |
| Gene Name | TRIP11 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1979 | |
| Subcellular Localization |
Golgi apparatus, cis-Golgi network membrane Peripheral membrane protein . Cytoplasm, cytoskeleton . Associates with the ends of centrosome-nucleated microtubules. |
|
| Protein Description | Binds the ligand binding domain of the thyroid receptor (THRB) in the presence of triiodothyronine and enhances THRB-modulated transcription. Golgi auto-antigen; probably involved in maintaining cis-Golgi structure.. | |
| Protein Sequence | MSSWLGGLGSGLGQSLGQVGGSLASLTGQISNFTKDMLMEGTEEVEAELPDSRTKEIEAIHAILRSENERLKKLCTDLEEKHEASEIQIKQQSTSYRNQLQQKEVEISHLKARQIALQDQLLKLQSAAQSVPSGAGVPATTASSSFAYGISHHPSAFHDDDMDFGDIISSQQEINRLSNEVSRLESEVGHWRHIAQTSKAQGTDNSDQSEICKLQNIIKELKQNRSQEIDDHQHEMSVLQNAHQQKLTEISRRHREELSDYEERIEELENLLQQGGSGVIETDLSKIYEMQKTIQVLQIEKVESTKKMEQLEDKIKDINKKLSSAENDRDILRREQEQLNVEKRQIMEECENLKLECSKLQPSAVKQSDTMTEKERILAQSASVEEVFRLQQALSDAENEIMRLSSLNQDNSLAEDNLKLKMRIEVLEKEKSLLSQEKEELQMSLLKLNNEYEVIKSTATRDISLDSELHDLRLNLEAKEQELNQSISEKETLIAEIEELDRQNQEATKHMILIKDQLSKQQNEGDSIISKLKQDLNDEKKRVHQLEDDKMDITKELDVQKEKLIQSEVALNDLHLTKQKLEDKVENLVDQLNKSQESNVSIQKENLELKEHIRQNEEELSRIRNELMQSLNQDSNSNFKDTLLKEREAEVRNLKQNLSELEQLNENLKKVAFDVKMENEKLVLACEDVRHQLEECLAGNNQLSLEKNTIVETLKMEKGEIEAELCWAKKRLLEEANKYEKTIEELSNARNLNTSALQLEHEHLIKLNQKKDMEIAELKKNIEQMDTDHKETKDVLSSSLEEQKQLTQLINKKEIFIEKLKERSSKLQEELDKYSQALRKNEILRQTIEEKDRSLGSMKEENNHLQEELERLREEQSRTAPVADPKTLDSVTELASEVSQLNTIKEHLEEEIKHHQKIIEDQNQSKMQLLQSLQEQKKEMDEFRYQHEQMNATHTQLFLEKDEEIKSLQKTIEQIKTQLHEERQDIQTDNSDIFQETKVQSLNIENGSEKHDLSKAETERLVKGIKERELEIKLLNEKNISLTKQIDQLSKDEVGKLTQIIQQKDLEIQALHARISSTSHTQDVVYLQQQLQAYAMEREKVFAVLNEKTRENSHLKTEYHKMMDIVAAKEAALIKLQDENKKLSTRFESSGQDMFRETIQNLSRIIREKDIEIDALSQKCQTLLAVLQTSSTGNEAGGVNSNQFEELLQERDKLKQQVKKMEEWKQQVMTTVQNMQHESAQLQEELHQLQAQVLVDSDNNSKLQVDYTGLIQSYEQNETKLKNFGQELAQVQHSIGQLCNTKDLLLGKLDIISPQLSSASLLTPQSAECLRASKSEVLSESSELLQQELEELRKSLQEKDATIRTLQENNHRLSDSIAATSELERKEHEQTDSEIKQLKEKQDVLQKLLKEKDLLIKAKSDQLLSSNENFTNKVNENELLRQAVTNLKERILILEMDIGKLKGENEKIVETYRGKETEYQALQETNMKFSMMLREKEFECHSMKEKALAFEQLLKEKEQGKTGELNQLLNAVKSMQEKTVVFQQERDQVMLALKQKQMENTALQNEVQRLRDKEFRSNQELERLRNHLLESEDSYTREALAAEDREAKLRKKVTVLEEKLVSSSNAMENASHQASVQVESLQEQLNVVSKQRDETALQLSVSQEQVKQYALSLANLQMVLEHFQQEEKAMYSAELEKQKQLIAEWKKNAENLEGKVISLQECLDEANAALDSASRLTEQLDVKEEQIEELKRQNELRQEMLDDVQKKLMSLANSSEGKVDKVLMRNLFIGHFHTPKNQRHEVLRLMGSILGVRREEMEQLFHDDQGGVTRWMTGWLGGGSKSVPNTPLRPNQQSVVNSSFSELFVKFLETESHPSIPPPKLSVHDMKPLDSPGRRKRDTNAPESFKDTAESRSGRRTDVNPFLAPRSAAVPLINPAGLGPGGPGHLLLKPISDVLPTFTPLPALPDNSAGVVLKDLLKQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSSWLGGLG ------CCCCCCCCC | 41.34 | 25944712 | |
| 2 | Phosphorylation | ------MSSWLGGLG ------CCCCCCCCC | 41.34 | - | |
| 3 | Phosphorylation | -----MSSWLGGLGS -----CCCCCCCCCC | 37.87 | - | |
| 42 | Phosphorylation | KDMLMEGTEEVEAEL HHHHHCCCCHHHHCC | 18.70 | 30576142 | |
| 55 | Ubiquitination | ELPDSRTKEIEAIHA CCCCCCHHHHHHHHH | 56.43 | 29967540 | |
| 66 | Phosphorylation | AIHAILRSENERLKK HHHHHHHCCHHHHHH | 41.13 | 30576142 | |
| 73 | Acetylation | SENERLKKLCTDLEE CCHHHHHHHCCHHHH | 54.08 | 7696051 | |
| 93 | Phosphorylation | EIQIKQQSTSYRNQL HHHHHHHHHHHHHHH | 19.48 | 24043423 | |
| 94 | Phosphorylation | IQIKQQSTSYRNQLQ HHHHHHHHHHHHHHH | 25.99 | 24043423 | |
| 95 | Phosphorylation | QIKQQSTSYRNQLQQ HHHHHHHHHHHHHHH | 27.60 | 24043423 | |
| 96 | Phosphorylation | IKQQSTSYRNQLQQK HHHHHHHHHHHHHHC | 17.42 | 24043423 | |
| 110 | Ubiquitination | KEVEISHLKARQIAL CCHHHHHHHHHHHHH | 3.56 | 29967540 | |
| 111 | Ubiquitination | EVEISHLKARQIALQ CHHHHHHHHHHHHHH | 35.78 | 29967540 | |
| 169 | Phosphorylation | MDFGDIISSQQEINR CCHHHHHHCHHHHHH | 23.56 | 29978859 | |
| 170 | Phosphorylation | DFGDIISSQQEINRL CHHHHHHCHHHHHHH | 26.02 | 29978859 | |
| 178 | Phosphorylation | QQEINRLSNEVSRLE HHHHHHHHHHHHHHH | 27.92 | 29978859 | |
| 182 | Phosphorylation | NRLSNEVSRLESEVG HHHHHHHHHHHHHHC | 25.60 | 29978859 | |
| 184 | Ubiquitination | LSNEVSRLESEVGHW HHHHHHHHHHHHCCH | 7.09 | 22817900 | |
| 186 | Ubiquitination | NEVSRLESEVGHWRH HHHHHHHHHHCCHHH | 42.02 | 22817900 | |
| 226 | Phosphorylation | KELKQNRSQEIDDHQ HHHHHCCCCCCCHHH | 39.45 | 28985074 | |
| 237 | Phosphorylation | DDHQHEMSVLQNAHQ CHHHHHHHHHHHHHH | 19.38 | 28555341 | |
| 248 | Phosphorylation | NAHQQKLTEISRRHR HHHHHHHHHHHHHHH | 38.00 | 23836654 | |
| 251 | Phosphorylation | QQKLTEISRRHREEL HHHHHHHHHHHHHHH | 19.61 | 24670416 | |
| 259 | Phosphorylation | RRHREELSDYEERIE HHHHHHHHHHHHHHH | 41.23 | 20873877 | |
| 261 | Phosphorylation | HREELSDYEERIEEL HHHHHHHHHHHHHHH | 19.13 | 20873877 | |
| 277 | Phosphorylation | NLLQQGGSGVIETDL HHHHCCCCCCHHCCH | 36.39 | - | |
| 296 | Ubiquitination | EMQKTIQVLQIEKVE HHHHHHHEEEEEEHH | 3.62 | 22817900 | |
| 299 | Ubiquitination | KTIQVLQIEKVESTK HHHHEEEEEEHHHCH | 4.90 | 22817900 | |
| 343 | 2-Hydroxyisobutyrylation | QEQLNVEKRQIMEEC HHHHCHHHHHHHHHH | 45.37 | - | |
| 383 | Phosphorylation | RILAQSASVEEVFRL HHHHHCCCHHHHHHH | 35.00 | 26471730 | |
| 395 | Phosphorylation | FRLQQALSDAENEIM HHHHHHHHHHHHHHH | 37.48 | 28348404 | |
| 405 | Phosphorylation | ENEIMRLSSLNQDNS HHHHHHHHHCCCCCC | 23.55 | - | |
| 406 | Phosphorylation | NEIMRLSSLNQDNSL HHHHHHHHCCCCCCH | 35.61 | 22199227 | |
| 412 | Phosphorylation | SSLNQDNSLAEDNLK HHCCCCCCHHHHHHH | 36.93 | 21815630 | |
| 417 | Ubiquitination | DNSLAEDNLKLKMRI CCCHHHHHHHHHHHH | 30.49 | 24816145 | |
| 418 | Ubiquitination | NSLAEDNLKLKMRIE CCHHHHHHHHHHHHH | 12.14 | 22817900 | |
| 419 | Ubiquitination | SLAEDNLKLKMRIEV CHHHHHHHHHHHHHH | 52.93 | 21906983 | |
| 420 | Ubiquitination | LAEDNLKLKMRIEVL HHHHHHHHHHHHHHH | 6.25 | 22817900 | |
| 421 | Ubiquitination | AEDNLKLKMRIEVLE HHHHHHHHHHHHHHH | 25.25 | 22817900 | |
| 432 | Phosphorylation | EVLEKEKSLLSQEKE HHHHHHHHHHHHCHH | 35.32 | 28348404 | |
| 444 | Phosphorylation | EKEELQMSLLKLNNE CHHHHHHHHHHHCCC | 20.00 | 24719451 | |
| 452 | Phosphorylation | LLKLNNEYEVIKSTA HHHHCCCHHHHHHHC | 20.02 | 28796482 | |
| 460 | Phosphorylation | EVIKSTATRDISLDS HHHHHHCCCCCCCCH | 29.03 | - | |
| 464 | Phosphorylation | STATRDISLDSELHD HHCCCCCCCCHHHHH | 30.34 | 29255136 | |
| 467 | Phosphorylation | TRDISLDSELHDLRL CCCCCCCHHHHHHHH | 47.56 | 23663014 | |
| 486 | Phosphorylation | KEQELNQSISEKETL HHHHHHHCCCHHHHH | 27.32 | 19664994 | |
| 488 | Phosphorylation | QELNQSISEKETLIA HHHHHCCCHHHHHHH | 48.11 | 23663014 | |
| 492 | Phosphorylation | QSISEKETLIAEIEE HCCCHHHHHHHHHHH | 34.24 | 18669648 | |
| 503 | Ubiquitination | EIEELDRQNQEATKH HHHHHHHCCHHHHHH | 56.47 | 22817900 | |
| 506 | Ubiquitination | ELDRQNQEATKHMIL HHHHCCHHHHHHHHH | 66.89 | 22817900 | |
| 508 | Phosphorylation | DRQNQEATKHMILIK HHCCHHHHHHHHHHH | 22.26 | 27251275 | |
| 527 | Phosphorylation | KQQNEGDSIISKLKQ HCCCCHHHHHHHHHH | 32.45 | 21815630 | |
| 530 | Phosphorylation | NEGDSIISKLKQDLN CCHHHHHHHHHHHCC | 30.20 | 27794612 | |
| 556 | Ubiquitination | DKMDITKELDVQKEK HCCCHHHHHHHHHHH | 41.37 | 22817900 | |
| 595 | Phosphorylation | LVDQLNKSQESNVSI HHHHHHHHHHHCCCH | 37.80 | 25159151 | |
| 596 | Ubiquitination | VDQLNKSQESNVSIQ HHHHHHHHHHCCCHH | 60.80 | 23000965 | |
| 601 | Phosphorylation | KSQESNVSIQKENLE HHHHHCCCHHHHHHH | 24.45 | 25159151 | |
| 602 | Ubiquitination | SQESNVSIQKENLEL HHHHCCCHHHHHHHH | 6.21 | 23000965 | |
| 621 | Phosphorylation | RQNEEELSRIRNELM HHCHHHHHHHHHHHH | 29.01 | 28258704 | |
| 624 | Ubiquitination | EEELSRIRNELMQSL HHHHHHHHHHHHHHH | 29.47 | 24816145 | |
| 630 | Phosphorylation | IRNELMQSLNQDSNS HHHHHHHHHCCCCCC | 18.47 | 29978859 | |
| 635 | Phosphorylation | MQSLNQDSNSNFKDT HHHHCCCCCCCHHHH | 32.18 | 29978859 | |
| 637 | Phosphorylation | SLNQDSNSNFKDTLL HHCCCCCCCHHHHHH | 47.82 | 29978859 | |
| 642 | Phosphorylation | SNSNFKDTLLKEREA CCCCHHHHHHHHHHH | 34.28 | 29978859 | |
| 659 | Phosphorylation | RNLKQNLSELEQLNE HHHHHHHHHHHHHHH | 47.92 | 25599653 | |
| 737 | Ubiquitination | KRLLEEANKYEKTIE HHHHHHHHHHHHHHH | 51.20 | 22817900 | |
| 738 | Ubiquitination | RLLEEANKYEKTIEE HHHHHHHHHHHHHHH | 62.93 | 22817900 | |
| 740 | Ubiquitination | LEEANKYEKTIEELS HHHHHHHHHHHHHHH | 45.38 | 22817900 | |
| 741 | Ubiquitination | EEANKYEKTIEELSN HHHHHHHHHHHHHHH | 52.27 | 22817900 | |
| 754 | Phosphorylation | SNARNLNTSALQLEH HHCCCCCCCHHHHHH | 20.67 | 29214152 | |
| 755 | Phosphorylation | NARNLNTSALQLEHE HCCCCCCCHHHHHHH | 26.38 | 25159151 | |
| 763 | Ubiquitination | ALQLEHEHLIKLNQK HHHHHHHHHHHHHHH | 34.46 | 22817900 | |
| 771 | Acetylation | LIKLNQKKDMEIAEL HHHHHHHHHHHHHHH | 53.17 | 22424773 | |
| 779 | Acetylation | DMEIAELKKNIEQMD HHHHHHHHHHHHHHC | 34.97 | 22424773 | |
| 787 | Phosphorylation | KNIEQMDTDHKETKD HHHHHHCCCCHHHHH | 34.36 | 29083192 | |
| 792 | Phosphorylation | MDTDHKETKDVLSSS HCCCCHHHHHHHHCC | 37.03 | 29083192 | |
| 799 | Phosphorylation | TKDVLSSSLEEQKQL HHHHHHCCHHHHHHH | 36.10 | 26437602 | |
| 803 | Ubiquitination | LSSSLEEQKQLTQLI HHCCHHHHHHHHHHH | 29.44 | 23000965 | |
| 807 | Phosphorylation | LEEQKQLTQLINKKE HHHHHHHHHHHHHHH | 20.88 | 26270265 | |
| 809 | Ubiquitination | EQKQLTQLINKKEIF HHHHHHHHHHHHHHH | 3.82 | 23000965 | |
| 812 | Acetylation | QLTQLINKKEIFIEK HHHHHHHHHHHHHHH | 44.80 | 25953088 | |
| 812 | Malonylation | QLTQLINKKEIFIEK HHHHHHHHHHHHHHH | 44.80 | 32601280 | |
| 813 | Malonylation | LTQLINKKEIFIEKL HHHHHHHHHHHHHHH | 52.10 | 26320211 | |
| 847 | Phosphorylation | KNEILRQTIEEKDRS HCHHHHHHHHHHHHC | 24.75 | 22210691 | |
| 858 | Ubiquitination | KDRSLGSMKEENNHL HHHCCCCHHHHHHHH | 6.34 | 24816145 | |
| 859 | Ubiquitination | DRSLGSMKEENNHLQ HHCCCCHHHHHHHHH | 64.67 | 24816145 | |
| 887 | Phosphorylation | APVADPKTLDSVTEL CCCCCHHHHHHHHHH | 40.98 | 23879269 | |
| 890 | Phosphorylation | ADPKTLDSVTELASE CCHHHHHHHHHHHHH | 33.77 | 27251275 | |
| 892 | Phosphorylation | PKTLDSVTELASEVS HHHHHHHHHHHHHHH | 29.27 | 27251275 | |
| 917 | Ubiquitination | EEIKHHQKIIEDQNQ HHHHHHHHHHHHHHH | 41.09 | 24816145 | |
| 965 | Ubiquitination | FLEKDEEIKSLQKTI HHHCHHHHHHHHHHH | 3.27 | 33845483 | |
| 966 | Ubiquitination | LEKDEEIKSLQKTIE HHCHHHHHHHHHHHH | 48.68 | 33845483 | |
| 969 | Ubiquitination | DEEIKSLQKTIEQIK HHHHHHHHHHHHHHH | 48.19 | 29967540 | |
| 970 | Ubiquitination | EEIKSLQKTIEQIKT HHHHHHHHHHHHHHH | 57.68 | 29967540 | |
| 975 | Ubiquitination | LQKTIEQIKTQLHEE HHHHHHHHHHHHHHH | 3.19 | 32015554 | |
| 976 | Ubiquitination | QKTIEQIKTQLHEER HHHHHHHHHHHHHHH | 29.88 | 32015554 | |
| 991 | Phosphorylation | QDIQTDNSDIFQETK HHHCCCCCCHHHHHC | 34.59 | 24719451 | |
| 997 | Ubiquitination | NSDIFQETKVQSLNI CCCHHHHHCCEEEEC | 26.23 | 22817900 | |
| 998 | Ubiquitination | SDIFQETKVQSLNIE CCHHHHHCCEEEECC | 37.21 | 22817900 | |
| 1001 | Phosphorylation | FQETKVQSLNIENGS HHHHCCEEEECCCCC | 26.77 | 28348404 | |
| 1008 | Phosphorylation | SLNIENGSEKHDLSK EEECCCCCCCCCCCH | 55.86 | 17192257 | |
| 1009 | Ubiquitination | LNIENGSEKHDLSKA EECCCCCCCCCCCHH | 56.67 | 33845483 | |
| 1010 | Ubiquitination | NIENGSEKHDLSKAE ECCCCCCCCCCCHHH | 44.08 | 33845483 | |
| 1037 | Ubiquitination | LEIKLLNEKNISLTK HHHHHHHHCCCCHHH | 47.66 | 23000965 | |
| 1038 | Ubiquitination | EIKLLNEKNISLTKQ HHHHHHHCCCCHHHH | 59.51 | 23000965 | |
| 1041 | Phosphorylation | LLNEKNISLTKQIDQ HHHHCCCCHHHHHHH | 39.10 | 24719451 | |
| 1043 | Ubiquitination | NEKNISLTKQIDQLS HHCCCCHHHHHHHCC | 17.70 | 23000965 | |
| 1044 | Ubiquitination | EKNISLTKQIDQLSK HCCCCHHHHHHHCCH | 51.02 | - | |
| 1044 | Ubiquitination | EKNISLTKQIDQLSK HCCCCHHHHHHHCCH | 51.02 | 23000965 | |
| 1055 | Ubiquitination | QLSKDEVGKLTQIIQ HCCHHHHHHHHHHHH | 19.74 | 33845483 | |
| 1056 | Ubiquitination | LSKDEVGKLTQIIQQ CCHHHHHHHHHHHHH | 54.24 | 33845483 | |
| 1086 | Phosphorylation | SHTQDVVYLQQQLQA CCCHHHHHHHHHHHH | 9.91 | 22817900 | |
| 1100 | 2-Hydroxyisobutyrylation | AYAMEREKVFAVLNE HHHHHHHHHHHHHCH | 49.20 | - | |
| 1124 | Ubiquitination | TEYHKMMDIVAAKEA HHHHHHHHHHHHHHH | 28.81 | 24816145 | |
| 1145 | Phosphorylation | DENKKLSTRFESSGQ HCCCCHHHHHHHCCH | 50.22 | 21712546 | |
| 1149 | Phosphorylation | KLSTRFESSGQDMFR CHHHHHHHCCHHHHH | 36.74 | 21712546 | |
| 1168 | Ubiquitination | NLSRIIREKDIEIDA HHHHHHHHCCCCHHH | 44.67 | 29967540 | |
| 1169 | Ubiquitination | LSRIIREKDIEIDAL HHHHHHHCCCCHHHH | 54.91 | 29967540 | |
| 1267 | Phosphorylation | NSKLQVDYTGLIQSY CCEEEEEEHHHHHHH | 12.12 | 22817900 | |
| 1274 | Phosphorylation | YTGLIQSYEQNETKL EHHHHHHHHHCHHHH | 12.73 | 25022875 | |
| 1279 | Phosphorylation | QSYEQNETKLKNFGQ HHHHHCHHHHHHHHH | 49.58 | 25022875 | |
| 1279 | Ubiquitination | QSYEQNETKLKNFGQ HHHHHCHHHHHHHHH | 49.58 | 29967540 | |
| 1280 | Ubiquitination | SYEQNETKLKNFGQE HHHHCHHHHHHHHHH | 51.81 | 29967540 | |
| 1313 | Phosphorylation | LGKLDIISPQLSSAS HCCCCCCCCCCCCCC | 13.61 | 28348404 | |
| 1318 | Phosphorylation | IISPQLSSASLLTPQ CCCCCCCCCCCCCCC | 30.39 | 28348404 | |
| 1320 | Phosphorylation | SPQLSSASLLTPQSA CCCCCCCCCCCCCCH | 26.34 | 28348404 | |
| 1323 | Phosphorylation | LSSASLLTPQSAECL CCCCCCCCCCCHHHH | 25.28 | 24719451 | |
| 1326 | Phosphorylation | ASLLTPQSAECLRAS CCCCCCCCHHHHHHC | 27.52 | 27251275 | |
| 1333 | Phosphorylation | SAECLRASKSEVLSE CHHHHHHCHHHHHHC | 30.22 | 24719451 | |
| 1333 | Ubiquitination | SAECLRASKSEVLSE CHHHHHHCHHHHHHC | 30.22 | 32015554 | |
| 1334 | Ubiquitination | AECLRASKSEVLSES HHHHHHCHHHHHHCH | 50.04 | 32015554 | |
| 1335 | Phosphorylation | ECLRASKSEVLSESS HHHHHCHHHHHHCHH | 30.37 | 29496963 | |
| 1339 | Phosphorylation | ASKSEVLSESSELLQ HCHHHHHHCHHHHHH | 40.38 | 28348404 | |
| 1341 | Phosphorylation | KSEVLSESSELLQQE HHHHHHCHHHHHHHH | 26.24 | 25849741 | |
| 1342 | Phosphorylation | SEVLSESSELLQQEL HHHHHCHHHHHHHHH | 28.36 | 21712546 | |
| 1355 | Phosphorylation | ELEELRKSLQEKDAT HHHHHHHHHHHCHHH | 28.93 | 24732914 | |
| 1358 | Ubiquitination | ELRKSLQEKDATIRT HHHHHHHHCHHHHHH | 59.19 | 24816145 | |
| 1359 | 2-Hydroxyisobutyrylation | LRKSLQEKDATIRTL HHHHHHHCHHHHHHH | 39.44 | - | |
| 1359 | Ubiquitination | LRKSLQEKDATIRTL HHHHHHHCHHHHHHH | 39.44 | 24816145 | |
| 1362 | Phosphorylation | SLQEKDATIRTLQEN HHHHCHHHHHHHHHC | 22.56 | 24732914 | |
| 1374 | Phosphorylation | QENNHRLSDSIAATS HHCCCHHCHHCHHHH | 29.30 | 21712546 | |
| 1376 | Phosphorylation | NNHRLSDSIAATSEL CCCHHCHHCHHHHHH | 15.68 | 28555341 | |
| 1399 | Methylation | DSEIKQLKEKQDVLQ HHHHHHHHHHHHHHH | 61.44 | - | |
| 1412 | 2-Hydroxyisobutyrylation | LQKLLKEKDLLIKAK HHHHHHHCCHHHHHC | 52.68 | - | |
| 1412 | Acetylation | LQKLLKEKDLLIKAK HHHHHHHCCHHHHHC | 52.68 | 25953088 | |
| 1432 | Ubiquitination | SSNENFTNKVNENEL CCCCCCCCCCCHHHH | 41.98 | 29967540 | |
| 1433 | Ubiquitination | SNENFTNKVNENELL CCCCCCCCCCHHHHH | 43.30 | 29967540 | |
| 1475 | Acetylation | IVETYRGKETEYQAL HHHHHCCCHHHHHHH | 53.09 | 7972651 | |
| 1477 | Phosphorylation | ETYRGKETEYQALQE HHHCCCHHHHHHHHH | 43.40 | 20068231 | |
| 1479 | Phosphorylation | YRGKETEYQALQETN HCCCHHHHHHHHHHC | 13.40 | 20068231 | |
| 1485 | Phosphorylation | EYQALQETNMKFSMM HHHHHHHHCCCHHHH | 27.87 | 20068231 | |
| 1490 | Phosphorylation | QETNMKFSMMLREKE HHHCCCHHHHHHHCH | 9.58 | 20068231 | |
| 1504 | Acetylation | EFECHSMKEKALAFE HHCCCCHHHHHHHHH | 60.11 | 20167786 | |
| 1522 | Phosphorylation | KEKEQGKTGELNQLL HHHHCCCHHHHHHHH | 42.59 | 20068231 | |
| 1660 | Phosphorylation | DETALQLSVSQEQVK CCCHHHHCCCHHHHH | 13.53 | 27251275 | |
| 1770 | Phosphorylation | DVQKKLMSLANSSEG HHHHHHHHHHCCCCC | 34.46 | 21406692 | |
| 1774 | Phosphorylation | KLMSLANSSEGKVDK HHHHHHCCCCCCCCH | 24.94 | 21406692 | |
| 1775 | Phosphorylation | LMSLANSSEGKVDKV HHHHHCCCCCCCCHH | 50.61 | 21406692 | |
| 1794 | Phosphorylation | LFIGHFHTPKNQRHE HHCCCCCCCHHHHHH | 34.71 | 28555341 | |
| 1808 | Phosphorylation | EVLRLMGSILGVRRE HHHHHHHHHHCCCHH | 10.73 | 20068231 | |
| 1833 | Phosphorylation | GGVTRWMTGWLGGGS CCCHHHCCCCCCCCC | 20.46 | 22985185 | |
| 1840 | Phosphorylation | TGWLGGGSKSVPNTP CCCCCCCCCCCCCCC | 25.65 | 27422710 | |
| 1841 | Phosphorylation | GWLGGGSKSVPNTPL CCCCCCCCCCCCCCC | 59.76 | 32142685 | |
| 1842 | Phosphorylation | WLGGGSKSVPNTPLR CCCCCCCCCCCCCCC | 44.50 | 29255136 | |
| 1845 | Phosphorylation | GGSKSVPNTPLRPNQ CCCCCCCCCCCCCCC | 52.77 | 32142685 | |
| 1846 | Phosphorylation | GSKSVPNTPLRPNQQ CCCCCCCCCCCCCCH | 20.03 | 25463755 | |
| 1854 | Phosphorylation | PLRPNQQSVVNSSFS CCCCCCHHHHCCCHH | 20.47 | 29255136 | |
| 1858 | Phosphorylation | NQQSVVNSSFSELFV CCHHHHCCCHHHHHH | 22.58 | 29255136 | |
| 1859 | Phosphorylation | QQSVVNSSFSELFVK CHHHHCCCHHHHHHH | 27.82 | 25159151 | |
| 1861 | Phosphorylation | SVVNSSFSELFVKFL HHHCCCHHHHHHHHH | 35.02 | 22617229 | |
| 1870 | Phosphorylation | LFVKFLETESHPSIP HHHHHHHCCCCCCCC | 44.96 | - | |
| 1882 | Phosphorylation | SIPPPKLSVHDMKPL CCCCCCCCCCCCCCC | 24.43 | 23403867 | |
| 1891 | Phosphorylation | HDMKPLDSPGRRKRD CCCCCCCCCCCCCCC | 36.62 | 29255136 | |
| 1904 | Phosphorylation | RDTNAPESFKDTAES CCCCCCHHHHHCHHH | 36.22 | 27251275 | |
| 1917 | Phosphorylation | ESRSGRRTDVNPFLA HHCCCCCCCCCCCCC | 42.83 | 28555341 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRIPB_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRIPB_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRIPB_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RB_HUMAN | RB1 | physical | 9256431 | |
| THA_HUMAN | THRA | physical | 9256431 | |
| PRS8_HUMAN | PSMC5 | physical | 8603043 | |
| A16L1_HUMAN | ATG16L1 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00678 | Achodrogenesis type IA | |||||
| OMIM Disease | ||||||
| Note=A chromosomal aberration involving TRIP11 may be a cause of acute myelogenous leukemia. Translocation t(5 | ||||||
| 14)(q33 | ||||||
| q32) with PDGFRB. The fusion protein may be involved in clonal evolution of leukemia and eosinophilia. | ||||||
| 200600 | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1842 AND THR-1846, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464; SER-1842 ANDTHR-1846, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1008, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1891, AND MASSSPECTROMETRY. | |